BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30427880)

  • 21. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.
    Tsai VW; Cooper J; Garan H; Natale A; Ptaszek LM; Ellinor PT; Hickey K; Downey R; Zei P; Hsia H; Wang P; Hunt S; Haddad F; Al-Ahmad A
    Circ Heart Fail; 2009 May; 2(3):197-201. PubMed ID: 19808340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter defribrillator shocks: a troubleshooting guide.
    Swerdlow CD; Zhang J
    Rev Cardiovasc Med; 2001; 2(2):61-72. PubMed ID: 12439383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life.
    Kinch Westerdahl A; Sjöblom J; Mattiasson AC; Rosenqvist M; Frykman V
    Circulation; 2014 Jan; 129(4):422-9. PubMed ID: 24243857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence regarding clinical use of microvolt T-wave alternans.
    Hohnloser SH; Ikeda T; Cohen RJ
    Heart Rhythm; 2009 Mar; 6(3 Suppl):S36-44. PubMed ID: 19168396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scaling characteristics of heart rate time series before the onset of ventricular tachycardia.
    Baumert M; Wessel N; Schirdewan A; Voss A; Abbott D
    Ann Biomed Eng; 2007 Feb; 35(2):201-7. PubMed ID: 17171301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and discrimination of tachycardia in ICDs manufactured by St. Jude Medical.
    Zdarek J; Israel CW
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):226-39. PubMed ID: 27605236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
    Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study.
    Wieneke H; Svendsen JH; Lande J; Spencker S; Martinez JG; Strohmer B; Toivonen L; Le Marec H; Garcia-Fernandez FJ; Corrado D; Huertas-Vazquez A; Uy-Evanado A; Rusinaru C; Reinier K; Foldesi C; Hulak W; Chugh SS; Siffert W
    J Am Heart Assoc; 2016 Nov; 5(12):. PubMed ID: 27895044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design.
    Auricchio A; Meijer A; Kurita T; Schloss E; Brinkman K; Claessens-van Ooijen M; Sterns L
    Europace; 2011 Oct; 13(10):1484-93. PubMed ID: 21669960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
    Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
    Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart Rate Variability Analysis to Predict Onset of Ventricular Tachyarrhythmias in Implantable Cardioverter Defibrillators.
    Parsi A; O'Loughlin D; Glavin M; Jones E
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():6770-6775. PubMed ID: 31947395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular arrhythmias in patients with implanted cardioverter defibrillators.
    John RM; Stevenson WG
    Trends Cardiovasc Med; 2012 Oct; 22(7):169-73. PubMed ID: 22902094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The subcutaneous cardioverter-defibrillator: When less is more].
    Kuschyk J; Rudic B; Akin I; Borggrefe M; Röger S
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):123-8. PubMed ID: 26058997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive power of T-wave alternans and of ventricular gradient hysteresis for the occurrence of ventricular arrhythmias in primary prevention cardioverter-defibrillator patients.
    Man S; De Winter PV; Maan AC; Thijssen J; Borleffs CJ; van Meerwijk WP; Bootsma M; van Erven L; van der Wall EE; Schalij MJ; Burattini L; Burattini R; Swenne CA
    J Electrocardiol; 2011; 44(4):453-9. PubMed ID: 21704222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients.
    Oswald H; Schultz-Wildelau C; Gardiwal A; Lüsebrink U; König T; Meyer A; Duncker D; Pichlmaier MA; Klein G; Strüber M
    Eur J Heart Fail; 2010 Jun; 12(6):593-9. PubMed ID: 20406799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.